Treatment of hyperkalaemia with intravenous salbutamol

Abstract

Thirteen children with hyperkalaemia were treated by intravenous infusions of salbutamol, 4 μg/kg over 20 minutes. Reductions in the mean (SD) plasma potassium concentrations, of 1.48 (0.5) and 1.64 (0.5) mmol/l were obtained at 40 and 120 minutes, respectively, after completion of the infusions. No side effects were noted.